Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinpu Yu

Showing results (11-20 of 113) with videos related to

Pageof 12
Sort By:
Cancer Biotherapy & Radiopharmaceuticals|July 3, 2008
CD4+T cells in CIKs (CD4+ CIKs) reversed resistance to fas-mediated apoptosis through CD40/CD40L ligation rather than IFN-gamma stimulationJinpu Yu, Weihong Zhang, Huawei Jiang, et al.
Oncotarget|January 6, 2017
Research progress of neuroblastoma related gene variationsYanna Cao, Yan Jin, Jinpu Yu, et al.
Molecular and Cellular Biochemistry|May 2, 2012
The therapeutic function of the chemokine RANTES on the H22 hepatoma ascites modelChunfang Hao, Yehui Shi, Jinpu Yu, et al.
Digestive Diseases and Sciences|August 28, 2013
The correlation between the subsets of tumor infiltrating memory T cells and the expression of indoleamine 2,3-dioxygenase in gastric cancerRupeng Zhang, Hui Liu, Fangxuan Li, et al.
BMC Cancer|January 28, 2023
MR imaging phenotypes and features associated with pathogenic mutation to predict recurrence or metastasis in breast cancerZhenzhen Shao, Jinpu Yu, Yanan Cheng, et al.
International Journal of Clinical Oncology|January 22, 2022
Perspectives on the role of breast cancer susceptibility gene in breast cancerNan Wu, Lijuan Wei, Lijuan Li, et al.
Cancer Genetics|June 13, 2021
A hereditary ovarian cancer family with rare pathogenic splicing mutation: Implications for variant interpretationKe Wang, Yingnan Ye, Lewen Bao, et al.
Oncotarget|September 24, 2016
BMP signaling and its paradoxical effects in tumorigenesis and disseminationLijie Zhang, Yingnan Ye, Xinxin Long, et al.
Neurochemical Research|June 19, 2012
Rosiglitazone suppresses glioma cell growth and cell cycle by blocking the transforming growth factor-beta mediated pathwayPeng Wang, Jinpu Yu, Qiang Yin, et al.
Frontiers in Immunology|February 24, 2017
Dysregulation of SOCS-Mediated Negative Feedback of Cytokine Signaling in Carcinogenesis and Its Significance in Cancer TreatmentMengmeng Jiang, Wen-Wen Zhang, Pengpeng Liu, et al.
Pageof 12

Showing results (11-20 of 113) with videos related to

Sort By:
Pageof 12
Cancer Biotherapy & Radiopharmaceuticals|July 3, 2008
CD4+T cells in CIKs (CD4+ CIKs) reversed resistance to fas-mediated apoptosis through CD40/CD40L ligation rather than IFN-gamma stimulationJinpu Yu, Weihong Zhang, Huawei Jiang, et al.
Oncotarget|January 6, 2017
Research progress of neuroblastoma related gene variationsYanna Cao, Yan Jin, Jinpu Yu, et al.
Molecular and Cellular Biochemistry|May 2, 2012
The therapeutic function of the chemokine RANTES on the H22 hepatoma ascites modelChunfang Hao, Yehui Shi, Jinpu Yu, et al.
Digestive Diseases and Sciences|August 28, 2013
The correlation between the subsets of tumor infiltrating memory T cells and the expression of indoleamine 2,3-dioxygenase in gastric cancerRupeng Zhang, Hui Liu, Fangxuan Li, et al.
BMC Cancer|January 28, 2023
MR imaging phenotypes and features associated with pathogenic mutation to predict recurrence or metastasis in breast cancerZhenzhen Shao, Jinpu Yu, Yanan Cheng, et al.
International Journal of Clinical Oncology|January 22, 2022
Perspectives on the role of breast cancer susceptibility gene in breast cancerNan Wu, Lijuan Wei, Lijuan Li, et al.
Cancer Genetics|June 13, 2021
A hereditary ovarian cancer family with rare pathogenic splicing mutation: Implications for variant interpretationKe Wang, Yingnan Ye, Lewen Bao, et al.
Oncotarget|September 24, 2016
BMP signaling and its paradoxical effects in tumorigenesis and disseminationLijie Zhang, Yingnan Ye, Xinxin Long, et al.
Neurochemical Research|June 19, 2012
Rosiglitazone suppresses glioma cell growth and cell cycle by blocking the transforming growth factor-beta mediated pathwayPeng Wang, Jinpu Yu, Qiang Yin, et al.
Frontiers in Immunology|February 24, 2017
Dysregulation of SOCS-Mediated Negative Feedback of Cytokine Signaling in Carcinogenesis and Its Significance in Cancer TreatmentMengmeng Jiang, Wen-Wen Zhang, Pengpeng Liu, et al.
Pageof 12